DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20193937

Incidence of thrombocytopenia in neonates receiving phototherapy for indirect hyperbilirubinemia: a prospective cohort study

Mubashir H. Shah, Ramya Vedula, Reashma Roshan

Abstract


Background: Thrombocytopenia as a side effect of phototherapy has not been mentioned in the standard literature but was described briefly as isolated case reports after the phototherapy came in vogue in 1958. The purpose of this study was to find the incidence of thrombocytopenia in neonates with uncomplicated indirect hyperbilirubinemia receiving phototherapy in a referral hospital.

Methods: This was a prospective cohort study conducted in a referral hospital over a period of 18 months from June 1, 2013 to November 1, 2014.

Results: A total of 103 babies were enrolled. The overall incidence of post-phototherapy thrombocytopenia was 45.6% while mild, moderate and severe thrombocytopenia was present in 66%, 21.3% and 12.8% of babies respectively. The lowest platelet count observed was 31,000/mm3 but none of the neonates showed bleeding manifestations. The incidence of thrombocytopenia following phototherapy was significantly higher in preterm babies, infants who received double surface phototherapy, babies who received phototherapy for >72 hours and in babies who received phototherapy on day 2 or 3 of life.

Conclusions: Neonates requiring phototherapy for hyperbilirubinemia are at risk of developing thrombocytopenia, hence the treatment should be initiated based on the standard guidelines. Unnecessary use and prolongation of phototherapy should be avoided considering the possible side effects. Platelet count should be monitored particularly in pre-term neonates receiving phototherapy. Neonates receiving double surface phototherapy and those requiring phototherapy for longer duration require more frequent platelet count monitoring.

 


Keywords


Hyperbilirubinemia, Incidence, Neonates, Phototherapy, Thrombocytopenia

Full Text:

PDF

References


Zieve P, Solomen M, Krevans JR. The effect of hematoporphyrin and light on human platelets. J Cell Physiol. 1966;67(2):28-4.

Maurer HM, Fratkin M, McWilliams NB, Kirkpatrick B, Draper D, Haggins JC, et al. Effects of phototherapy on platelet counts in low birth weight infants and on platelet production and life span in rabbits. Pediatr. 1976;57(4):506-12.

American Academy of Pediatrics Sub-committee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatr. 2004;114(1):297-316.

Ali N, Auerbach HE. New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach. J Community Hosp Intern Med Perspect. 2017;7(3): 15767.

Khera MS, Gupta CR. Incidence of thrombocytopenia following phototherapy in hyperbilirubinemic neonates. MJAFI. 2011 Oct 1;67(4):329-32.

Boskabadi H, Mafinezhad S, Bagher F, Bozorgina Y. Incidence of thrombocytopenia in idiopathic hyperbilirubinemic newborns. Maced J Med Sci. 2014;7(2):261-4.

Tawab CN, Saldanha PR, Mithun HK. Phototherapy induced thrombocytopenia-A comparative study among breast fed term and preterm neonates with hyperbilirubinemia, International journal of medical and health sciences. 2014;3(4):256-60.

Pishva, N, Pishva H. Incidence of thrombocytopenia in hyperbilirubinemic neonates during phototherapy. Acta Medica Iranica 2000;38:7-9.

Monsef A, Eghbalian F. Does conventional phototherapy have any effect on platelet count in full term neonates with indirect hyperbilirubinemia? Health 2011;3(12):709-11.